原发性甲状腺功能减退症合并垂体增生临床治疗研究

Primary hypothyroidism on clinical research for the treatment of complications of pituitary hyperplasia

目的：研究左旋甲状腺素治疗原发性甲状腺功能减退症合并垂体增生患者的临床效果和安全性. 方法：利用回顾性研究方法,我们随机选择了我院于2013年1月1日~2014年7月31日收治的46例原发性甲状腺功能减退症合并垂体增生患者作为研究对象. 将此46例原发性甲状腺功能减退症合并垂体增生患者随机分为实验组和对照组,实验组23例运用左旋甲状腺素治疗,对照组23例采用常规方法进行治疗. 观察统计2组原发性甲状腺功能减退症合并垂体增生患者的临床治疗效果. 以此来明晰左旋甲状腺素治疗原发性甲状腺功能减退症合并垂体增生的重要作用. 结果：运用左旋甲状腺素的实验组的治疗有效率为91.30%,对照组治疗有效率为73.91%,实验组患者治疗有效率明显好于对照组患者（P〈0.05）. 结论：左旋甲状腺素治疗原发性甲状腺功能减退症合并垂体增生患者,能够显著提高治疗有效率,效果显著,值得临床借鉴和推广.

Objective：To study the levothyroxine treatment of primary hypothyroidism in the clinical efficacy and safety of patients with pituitary hyperplasia.Methods：Using the method of retrospective study, we randomly selected in our hospital in January 1, 2013 -2014 year in July 31st admitted 46 cases of primary hypothyroidism patients with pituitary hyperplasia as the research object.The 46 cases of primary hypothyroidism patients with pituitary hyperplasia were randomly divided into experimental group and control group, 23 cases in the experimental group with levothyroxine therapy, 23 cases in the control group were treated by routine method.On the observation and statistics of two groups of primary hypothyroidism in the clinical treatment effect of patients with pituitary hyperplasia disease.In order to clarify the important role of levothyroxine treatment of primary hypothyroidism with pituitary hyperplasia.Results：The effective rate of the experimental group with levothyroxine therapy was 91.30%, the effective rate of treatment group were 73.91%, the effective rate of the treatment of patients in the experimental group was significantly better than the control group patients （P〈0.05）.Conclusion：Levothy-roxine treatment of primary hypothyroidism patients with pituitary hyperplasia, can significantly improve the treatment efficiency, the effect is significant, worthy of clinical reference and promotion.